Experts say MLOps will bridge the gap between development and operations, creating room for the inclusion of security and privacy practices, too.

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public.

The integration of augmented reality and artificial intelligence is advancing wearable technology, with smart glasses emerging as a significant innovation. Thes ...

The future of work requires data teams to lead with data governance, ops, and products that make data reliable and ...

Before deploying agentic AI, enterprises should be prepared to address several issues that could impact the trustworthiness ...

While every sector is preparing for a future which involves new technologies such as AI and machine learning, the logistics ...

Experts share predictions and strategies for safeguarding the future from AI-driven attacks to post-quantum challenges.

Key steps to consider before introducing GenAI include evaluating data readiness, ensuring secure platforms and establishing ...

Nvidia's Cosmos platform lets researchers simulate multiple different realities and simulate real-world physics to generate ...

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

In the case of Microsoft and AI, that's not something being considered, as the software giant plans on spending $80 billion ...

AI agents will change work forever. To embrace that chance, business leaders must focus on what matters most - designing and cultivating healthy and sustainable relationships.